Prophylactic antithrombin III (ATIII) in children at high risk of veno-occlusive disease (VOD) after hematopoietic stem cell transplantation.

被引：0
|
作者：
Carret, AS
Wilson-Plat, G
Briquel, ME
Andre, E
Lecompte, T
Bordigoni, P
机构：
[1] Hop Enfants, Bone Marrow Transplantat Unit, Nancy, France
[2] CHU Brabois, Hemostasis Lab, Nancy, France
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5165
引用
收藏
页码：328B / 328B
页数：1
相关论文
共 50 条
  • [21] The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan
    Chien-Chang Lee
    Hsiu-Hao Chang
    Meng-Yao Lu
    Yung-Li Yang
    Shu-Wei Chou
    Dong-Tsamn Lin
    Shiann-Tarng Jou
    Ming Yao
    Chi-Cheng Li
    Su-Peng Yeh
    Mei-Hui Chen
    Jyh-Pyng Gau
    Sin-Syue Li
    Po-Nan Wang
    Yi-Chang Liu
    Tso-Fu Wang
    Tran-Der Tan
    Ming-Yang Lee
    Ming-Sun Yu
    Chuan-Cheng Wang
    Shih-Chiang Lin
    Yeu-Chin Chen
    Yung-Cheng Su
    Ko-Ying Su
    Kai-Hsin Lin
    Annals of Hematology, 2019, 98 : 745 - 752
  • [22] Prevention of Veno-Occlusive Disease (VOD) with Defibrotide in High-Risk Pediatric Hematopoietic Stem Cell Transplant Patients
    Wass, Erika Nicole
    Lovejoy, Beverly
    Glover, Nicolle
    Zhao, Quan
    Sosa, Walter
    Chavan, Rishikesh
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S289 - S289
  • [23] Veno-Occlusive Disease (VOD) after Hematopoietic Stem Cell Transplant (HSCR): Always a Catastrophic Illness?
    Bernasconi, Paolo
    Colombo, Anna Amelia
    Caldera, Daniela
    Borsani, Oscar
    BLOOD, 2019, 134
  • [24] A Multicenter Prospective Phase II Study of Antithrombin-III Based Treatment for Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation
    Hong, Che Ry
    Lee, Ji Won
    Eom, Hyeon-Seok
    Yoo, Keon Hee
    Lee, Jong Wook
    Im, Ho Joon
    Shin, Hee Young
    Kang, Hyoung Jin
    BLOOD, 2016, 128 (22)
  • [25] Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation
    A Tefferi
    S Kumar
    RC Wolf
    MQ Lacy
    DJ Inwards
    JM Gloor
    RC Albright
    PS Kamath
    MR Litzow
    Bone Marrow Transplantation, 2001, 28 : 997 - 999
  • [26] Hepatic veno-occlusive disease following hematopoietic stem cell transplantation
    Richardson, P
    Guinan, E
    ACTA HAEMATOLOGICA, 2001, 106 (1-2) : 57 - 68
  • [27] Hormonal therapy after stem cell transplantation and the risk of veno-occlusive disease
    Sica, S
    Salutari, P
    Chiusolo, P
    Cicconi, S
    Sorá, F
    Laurenti, L
    Piccirillo, N
    Scirpa, P
    Leone, G
    BLOOD, 1999, 93 (09) : 3154 - 3154
  • [28] Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation
    Tefferi, A
    Kumar, S
    Wolf, RC
    Lacy, MQ
    Inwards, DJ
    Gloor, JM
    Albright, RC
    Kamath, PS
    Litzow, MR
    BONE MARROW TRANSPLANTATION, 2001, 28 (10) : 997 - 999
  • [29] Defibrotide effectively prevents veno-occlusive disease of the liver (VOD) after allogeneic stem cell transplantation. An extended study.
    Chalandon, Yves
    Roosnek, Eddy
    Helg, Claudine
    Verholen, Frank
    Knipp, Sabine
    Ozsahin, Hulya
    Passweg, Jakob R.
    BLOOD, 2006, 108 (11) : 840A - 840A
  • [30] Allogeneic hematopoietic cell transplantation in systemic mastocytosis: is there a high risk for veno-occlusive disease?
    Ustun, Celalettin
    Smith, Angela
    Cayci, Zuzan
    Courville, Elizabeth L.
    Corbacioglu, Selim
    Akin, Cem
    Horny, Hans Peter
    Valent, Peter
    Devine, Steven
    Weisdorf, Daniel J.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (06) : 655 - 657
12345